Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1

Abstract

Nitric oxide (NO) activates corpus cavernosum smooth muscle soluble guanylate cyclase (sGC) and increases the synthesis of cGMP that results in smooth muscle relaxation and ultimately, penile erection. To characterize sGC and define the potential synergy between NO and the allosteric activator YC-1 in corpus cavernosum, rat sGC was activated by either sodium nitroprusside (SNP) or YC-1, and YC-1 potentiated the effects of SNP with a 200-fold activation of sGC. Both SNP and YC-1 decreased the Km and increased the Vmax. ODQ significantly inhibited sGC activated by SNP with IC50 of 0.5 nM, but did not affect the sGC activated by YC-1 as well as basal sGC activity. SNP and YC-1 synergistically increased intracellular cGMP levels in rabbit corpus cavernosum smooth muscle cell cultures. YC-1 significantly relaxed rabbit cavernosum tissue strips in organ baths with an EC50 of 8.4 μM. In the presence of L-nitroarginine methyl ester to block endogenous NO production, co-administration of SNP shifted the dose response of YC-1 to the left, showing the synergism of SNP and YC-1 in tissue strips. In view of the clinical efficacy of phosphodiesterase-5 inhibitors, activation of sGC may provide an alternative means for enhancing the activity of neurally derived NO during sexual stimulation in the corpus cavernosum, representing a novel approach for the treatment of erectile dysfunction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Behrends S, Steenpass A, Porst H, Scholz H. . Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum. Biochem Pharmacol 2000 59: 713–717.

    Article  CAS  PubMed  Google Scholar 

  2. Klotz T et al . Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum. Int J Impot Res 2000 12: 157–164.

    Article  CAS  PubMed  Google Scholar 

  3. Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM. . YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 1995 116: 1973–1978.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Stone JR, Marletta MA. . Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 1998 5: 255–261.

    Article  CAS  PubMed  Google Scholar 

  5. Friebe A, Koesling D. . Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 1998 53: 123–127.

    Article  CAS  PubMed  Google Scholar 

  6. Nakane M, Saheki S, Kuno T, Ishii K, Murad F. . Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem Biophys Res Commun 1988 157: 1139–1147.

    Article  CAS  PubMed  Google Scholar 

  7. Nakane M, Arai K, Saheki S, Kuno T, Buechler W, Murad F. . Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 1990 265: 16841–16845.

    CAS  PubMed  Google Scholar 

  8. O'Reilly DR. . Use of baculovirus expression vectors. Methods Mol Biol 1997 62: 235–246.

    CAS  PubMed  Google Scholar 

  9. Hoenicka M et al . Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. J Mol Med 1999 77: 14–23.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta S et al . The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle. Br J Pharmacol 1998 123: 1237–1245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hussain AS, Marks GS, Brien JF, Nakatsu K. . The soluble guanylyl cyclase inhibitor 1H-[1,2,4] oxadiazolo [4,3-alpha] quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 1997 75: 1034–1037.

    Article  CAS  PubMed  Google Scholar 

  12. Zhao Y et al . Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 2000 39: 10848–10854.

    Article  CAS  PubMed  Google Scholar 

  13. Wegener JW, Closs EI, Forstermann U, Nawrath H. . Failure of 1H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes. Br J Pharmacol 1999 127: 693–700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ko FN et al . YC-1, a novel activator of platelet guanylate cyclase. Blood 1994 84: 4226–4233.

    CAS  PubMed  Google Scholar 

  15. Teng CM et al . YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 1997 320: 161–166.

    Article  CAS  PubMed  Google Scholar 

  16. Brandish PE, Buechler W, Marletta MA. . Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin. Biochemistry 1998 37: 16898–16907.

    Article  CAS  PubMed  Google Scholar 

  17. Stasch JP et al . NO-independent regulatory site on soluble guanylate cyclase. Nature 2001 410: 212–215.

    Article  CAS  PubMed  Google Scholar 

  18. Friebe A, Russwurm M, Mergia E, Koesling D. . A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: implications for the YC-1 binding site? Biochemistry 1999 38: 15253–15257.

    Article  CAS  PubMed  Google Scholar 

  19. Denninger JW et al . Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies. Biochemistry 2000 39: 4191–4198.

    Article  CAS  PubMed  Google Scholar 

  20. Mulsch A et al . Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 1997 120: 681–689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wegener JW, Gath I, Forstermann U, Nawrath H. . Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br J Pharmacol 1997 122: 1523–1529.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Wohlfart P et al . Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol 1999 128: 1316–1322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Annemarie Rueter and Robert Simmer for helping the expression of sGC in Baculovirus system.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Nakane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakane, M., Hsieh, G., Miller, L. et al. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. Int J Impot Res 14, 121–127 (2002). https://doi.org/10.1038/sj.ijir.3900843

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900843

Keywords

This article is cited by

Search

Quick links